- Withdrawal of Registration Statement (RW)
December 19 2008 - 6:01AM
Edgar (US Regulatory)
December 18, 2008
VIA EDGAR AND FEDERAL EXPRESS
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
|
|
|
Re:
|
|
PharmaNet Development Group, Inc.
Request to Withdraw Registration Statement on Form S-4
File No. 333-155496
|
Ladies and Gentlemen:
In accordance with Rule 477 under the Securities Act of 1933 (the Securities Act), PharmaNet
Development Group, Inc. (the Registrant) hereby respectfully requests withdrawal of the above
referenced registration statement on Form S-4 (the Registration Statement), together with all
exhibits thereto, in accordance with and subject to Rule 477.
The Registrant is requesting withdrawal of the Registration Statement because the exchange
offer to which the Registration Statement relates was allowed to terminate on 11:59 PM on its
expiration date. The Registration Statement has not yet been declared effective and no securities
have been sold or exchanged pursuant thereto. The Registrant believes that the withdrawal of the
Registration Statement is consistent with the public interest and protection of investors, as
contemplated by Rule 477(a) under the Securities Act.
The Registrant also requests in accordance with Rule 457(p) of the Securities Act that all
fees paid to the Commission in connection with the filing of the Registration Statement be credited
to the account of the Registrant for future use.
If you have any questions with respect to this request, please call Emilio Ragosa, Esq. of
Morgan, Lewis & Bockius LLP, counsel to the Registrant, at (609) 919-6633.
|
|
|
|
|
|
Sincerely,
PHARMANET DEVELOPMENT GROUP, INC.
|
|
|
/s/ John Hamill
|
|
|
John Hamill
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
Pharmanet Development Grp (MM) (NASDAQ:PDGI)
Historical Stock Chart
From Jul 2024 to Jul 2024
Pharmanet Development Grp (MM) (NASDAQ:PDGI)
Historical Stock Chart
From Jul 2023 to Jul 2024